Pazdur to Deliver Keynote at AACI/CCAF Annual Meeting

Richard Pazdur, MD, Director, Office of Hematology Oncology Products, Food and Drug Administration, will be the opening keynote speaker for the 2016 AACI/CCAF Annual Meeting, October 23-25, in Chicago. Dr. Pazdurís talk will focus on the current state of drug development in the era of precision medicine and immuno-oncology as viewed from his unique perspective as both a regulator and an advocate.

Online registration continues for the meeting, and the regular registration rate will remain in effect through September 22. Information on the meeting, including the program and electronic registration is available on the AACI website.

The meeting will bring together AACI cancer center leadersódirectors and executive-level administratorsówith representatives from national cancer research and advocacy organizations, industry, and government health agencies. No other program presents information on cancer research and patient care issues as they pertain to academic cancer centers and fosters discussion of common challenges and opportunities and current practices to address them.

AACI and the Cancer Center Administrators Forum (CCAF) developed the program, in conjunction with the 2016 Annual Meeting program committee, chaired by Scott Lippman, MD, Director, UC San Diego Moores Cancer Center.